id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
VA-2010-VHA-0012-0011,VA,VA-2010-VHA-0012,Impact Analysis on AN42-Final Rule,Supporting & Related Material,,2012-03-05T05:00:00Z,2012,3,,,2012-03-05T16:09:41Z,,0,0,0900006480fceecf
VA-2010-VHA-0012-0010,VA,VA-2010-VHA-0012,AN42 - Final Rule - Drug and Drug-Related Supply Promotion by Pharmaceutical Company Representatives at VA Facilities,Rule,,2012-03-05T05:00:00Z,2012,3,,,2012-03-05T15:04:41Z,2012-05279,0,0,0900006480fcec8d
VA-2010-VHA-0012-0002,VA,VA-2010-VHA-0012,AN42 - Republished Proposed Rule - Drug and Drug-Related Supply Promotion by Pharmaceutical Company Sales Representatives at VA Facilities,Proposed Rule,,2010-05-11T04:00:00Z,2010,5,2010-05-11T04:00:00Z,2010-07-13T03:59:59Z,2011-06-11T15:54:42Z,2010-11170,0,0,0900006480aeb170
VA-2010-VHA-0012-0001,VA,VA-2010-VHA-0012,AN42 - Proposed Rule - Drug and Drug-Related Supply Promotion by Pharmaceutical Company Sales Representatives at VA Facilities,Proposed Rule,,2010-05-05T04:00:00Z,2010,5,2010-05-05T04:00:00Z,2010-07-07T03:59:59Z,2011-06-11T15:54:39Z,2010-10629,0,0,0900006480ae71e7